Authors

• Sonia Boulakirba (ORCID: https://orcid.org/0000-0001-7089-0860)
• Marion David (ORCID: https://orcid.org/0009-0001-0985-1835)
• Laura Bouchareychas (ORCID: https://orcid.org/0000-0003-4962-9750)
• David Fenard (ORCID: https://orcid.org/0000-0003-0242-386X)
• S. Beghelli
• Maurus de la Rosa (ORCID: https://orcid.org/0000-0002-6744-025X)
• Marion Ayrault (ORCID: https://orcid.org/0000-0001-8556-7062)
• Gaëlle Saviane
• Julie Gertner-Dardenne
• Satria P. Sajuthi (ORCID: https://orcid.org/0000-0001-9598-7298)
• Alexandra Demory
• Candice Navarin
• Jihane Frikeche
• Yue Cui (ORCID: https://orcid.org/0000-0002-1638-2619)
• Hsiaomei Heidi Lu
• Gregory Lara
• Alexandra Menardi
• Sandrine Rouquier
• Audrey Lafon
• Tobias Abel
• Céline Dumont (ORCID: https://orcid.org/0000-0003-1450-8713)

Institutions

• Sangamo BioSciences (United States) (US)

Publication Details

Journal

Journal of Crohn s and Colitis

Published

2024-09-09

DOI

https://doi.org/10.1093/ecco-jcc/jjae135

Citations

29

Primary Topic

Inflammatory Bowel Disease

Type

article

Field-Weighted Citation Impact

15.96

Funders

• Sangamo Therapeutics